Mage Biologics Inc.
PrivateLast Round
Corporate Funding
Jul 20, 2023
Total Funding Raised
$28M
Company Overview
Mage Biologics Inc. operates in Healthcare & Life Sciences and is based in Newark, Delaware. Its latest recorded funding round was a Corporate Funding round in July 2023.
Mage Biologics Inc. is a biotechnology company that develops orally administered monoclonal antibodies for the treatment of inflammatory bowel diseases such as ulcerative colitis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mage Biologics Inc. Comparables
Compare Mage Biologics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sorriso Therapeutics | 84% | |
| Rafael Holdings, Inc. | 74% | |
| Bristol Myers Squibb | 72% |
For institutional investors. Book with your work email.
Mage Biologics Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Mage Biologics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TVM Capital | Corporate Funding |
Mage Biologics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mage Biologics Inc.'s valuation, stock price, and market status.
Is Mage Biologics Inc. a public or private company?
Mage Biologics Inc. is a private company.
What is the current stock price of Mage Biologics Inc.?
Mage Biologics Inc. is a private company, so its shares have no public market price. Caplight tracks Mage Biologics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mage Biologics Inc. worth (valuation)?
Valuation information for Mage Biologics Inc. is not publicly available.
Can I buy Mage Biologics Inc. stock?
Mage Biologics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mage Biologics Inc.'s last funding round?
Mage Biologics Inc.'s most recent funding round was Corporate Funding on July 20, 2023.
Who are the main investors in Mage Biologics Inc.?
Key investors in Mage Biologics Inc. include TVM Capital.
Will Mage Biologics Inc. IPO soon?
No public IPO plans have been announced for Mage Biologics Inc..
How can I track Mage Biologics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Mage Biologics Inc.'s shares on secondary markets.